DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Eperisone is an investigational drug.
There have been 12 clinical trials for Eperisone. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2011.
The most common disease conditions in clinical trials are Back Pain, Spasm, and Low Back Pain. The leading clinical trial sponsors are Tanta University, Eisai Co., Ltd., and Daewon Pharmaceutical Co., Ltd.
Recent Clinical Trials for Eperisone
|Radial Extracorporeal Shock Wave Therapy for Chronic Non-specific Low Back Pain||Ludwig-Maximilians - University of Munich||N/A|
|Radial Extracorporeal Shock Wave Therapy for Chronic Non-specific Low Back Pain||First Affiliated Hospital of Zhejiang University||N/A|
|Cyclobenzaprine in Muscle Cramps With Liver Cirrhosis||Tanta University||Phase 3|